IL138950A0 - Stable compositions comprising levosimendan and alginic acid - Google Patents

Stable compositions comprising levosimendan and alginic acid

Info

Publication number
IL138950A0
IL138950A0 IL13895099A IL13895099A IL138950A0 IL 138950 A0 IL138950 A0 IL 138950A0 IL 13895099 A IL13895099 A IL 13895099A IL 13895099 A IL13895099 A IL 13895099A IL 138950 A0 IL138950 A0 IL 138950A0
Authority
IL
Israel
Prior art keywords
levosimendan
alginic acid
stable compositions
compositions
stable
Prior art date
Application number
IL13895099A
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL138950A0 publication Critical patent/IL138950A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL13895099A 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid IL138950A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid

Publications (1)

Publication Number Publication Date
IL138950A0 true IL138950A0 (en) 2001-11-25

Family

ID=8551576

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13895099A IL138950A0 (en) 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid
IL138950A IL138950A (en) 1998-04-23 2000-10-11 Stable compounds containing bosimandan and alginic acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138950A IL138950A (en) 1998-04-23 2000-10-11 Stable compounds containing bosimandan and alginic acid

Country Status (33)

Country Link
US (1) US6531458B1 (pt)
EP (1) EP1079834B1 (pt)
JP (1) JP4475809B2 (pt)
KR (1) KR100590622B1 (pt)
CN (1) CN1165309C (pt)
AT (1) ATE231395T1 (pt)
AU (1) AU756338B2 (pt)
BG (1) BG64766B1 (pt)
BR (1) BR9909867A (pt)
CA (1) CA2329232C (pt)
CZ (1) CZ290911B6 (pt)
DE (1) DE69905034T2 (pt)
DK (1) DK1079834T3 (pt)
EA (1) EA002428B1 (pt)
EE (1) EE04143B1 (pt)
ES (1) ES2191426T3 (pt)
FI (1) FI980902A (pt)
GE (1) GEP20032942B (pt)
HK (1) HK1031998A1 (pt)
HR (1) HRP20000703B1 (pt)
HU (1) HUP0105446A3 (pt)
ID (1) ID26650A (pt)
IL (2) IL138950A0 (pt)
MX (1) MXPA00010368A (pt)
NO (1) NO318575B1 (pt)
NZ (1) NZ507455A (pt)
PL (1) PL192274B1 (pt)
PT (1) PT1079834E (pt)
RS (1) RS49955B (pt)
SK (1) SK284600B6 (pt)
TR (1) TR200003101T2 (pt)
WO (1) WO1999055337A1 (pt)
ZA (1) ZA200005630B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
WO2002064120A1 (fr) * 2001-02-13 2002-08-22 Taisho Pharmaceutical Co., Ltd. Preparations de gel a usage interne
US20080194567A1 (en) * 2005-03-14 2008-08-14 Piero Pollesello Combination Treatment for Enhancing Diuresis
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
AU555304B2 (en) * 1982-04-05 1986-09-18 Merck Sharp & Dohme Limited Stabilization of drugs in alginic acid and magnesium hydroxide granules
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
PL192274B1 (pl) 2006-09-29
ID26650A (id) 2001-01-25
EP1079834B1 (en) 2003-01-22
AU756338B2 (en) 2003-01-09
NZ507455A (en) 2002-02-01
GEP20032942B (en) 2003-04-25
CN1165309C (zh) 2004-09-08
EE04143B1 (et) 2003-10-15
YU64000A (sh) 2002-12-10
SK15552000A3 (sk) 2001-05-10
JP4475809B2 (ja) 2010-06-09
CA2329232C (en) 2007-10-30
SK284600B6 (sk) 2005-07-01
DK1079834T3 (da) 2003-04-07
DE69905034D1 (de) 2003-02-27
ATE231395T1 (de) 2003-02-15
DE69905034T2 (de) 2003-09-04
RS49955B (sr) 2008-09-29
NO318575B1 (no) 2005-04-11
EA002428B1 (ru) 2002-04-25
EP1079834A1 (en) 2001-03-07
FI980902A (fi) 1999-10-24
PT1079834E (pt) 2003-04-30
BR9909867A (pt) 2000-12-19
NO20005312L (no) 2000-11-21
NO20005312D0 (no) 2000-10-20
EE200000616A (et) 2002-06-17
IL138950A (en) 2006-08-20
CN1298303A (zh) 2001-06-06
CZ20003779A3 (en) 2001-05-16
CZ290911B6 (cs) 2002-11-13
FI980902A0 (fi) 1998-04-23
WO1999055337A1 (en) 1999-11-04
MXPA00010368A (es) 2002-07-02
PL343722A1 (en) 2001-09-10
KR100590622B1 (ko) 2006-06-19
AU3524899A (en) 1999-11-16
BG104958A (en) 2001-07-31
HRP20000703A2 (en) 2001-04-30
HUP0105446A2 (hu) 2002-07-29
EA200001097A1 (ru) 2001-04-23
CA2329232A1 (en) 1999-11-04
HUP0105446A3 (en) 2002-09-30
TR200003101T2 (tr) 2001-01-22
HRP20000703B1 (en) 2009-11-30
US6531458B1 (en) 2003-03-11
KR20010072577A (ko) 2001-07-31
HK1031998A1 (en) 2001-07-06
ZA200005630B (en) 2002-01-14
BG64766B1 (bg) 2006-03-31
JP2002512964A (ja) 2002-05-08
ES2191426T3 (es) 2003-09-01

Similar Documents

Publication Publication Date Title
BG103190A (en) Substituted pyrimidine derivatives and their pharmaceutical application
IL129068A0 (en) Sulfinic acid derivatives and their preparation and use
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
MY122383A (en) Cyclic boroproline compounds
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
AU3227700A (en) Skin sanitizing compositions
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
EP0902789A4 (pt)
HK1052137A1 (en) Stabilized ascorbic acid solutions.
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
HK1031998A1 (en) Stable compositions comprising levosimendan and alginic acid
BG102814A (en) New derivatives of carboxylic acid, their preparation and application
GB9616896D0 (en) Pharmaceutical compositions
MD554G2 (ro) Derivaţi noi ai triazolpirimidinelor, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice care le conţin
EA199900006A1 (ru) Препарат и способ для лечения застоной сердечной недостаточности
UA10455A (uk) Склад для обробки пласта
HUP9802142A2 (hu) Na+/H+ -ioncsere inhibítorok alkalmazása a központi idegrendszer betegségeinek kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására
DE69626010D1 (de) Verwendung von tropolon derivate zur hemmung des inositmono phosphatase
UA32150A (uk) Спосіб лікування виразкової хвороби гастродуоденальної локалізації
ES2148057A1 (es) Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed